84 BoArD oF Directors At 31 DeceMBer 2008 louIS SChWEITZER 66 dAvId BRENNAN 55 SImoN loWTh 47 Non-Executive Chairman, Executive Director and Executive Director and Chairman of the Nomination Chief Executive Officer Chief Financial Officer and Governance Committee and Member of the Remuneration Committee mARCuS WAllENBERG 52 JohN vARlEY 52 JohN BuChANAN 65 Non-Executive Director Non-Executive Director, Non-Executive Director, Chairman of the Remuneration Committee Chairman of the Audit Committee and and Member of the Nomination and Member of the Remuneration Committee Governance Committee JohN pATTERSoN CBE FRCp 60 hKAN moGREN KBE 64 mIChElE hoopER 57 Executive Director, Development and Non-Executive Deputy Chairman and Senior Non-Executive Director, Member of the Science Committee Member of the Nomination and Member of the Audit Committee and the Governance Committee Nomination and Governance Committee dAmE NANCY RoThWEll 53 JANE hENNEY 61 Bo ANGElIN 59 Non-Executive Director, Non-Executive Director, Non-Executive Director and Chairman of the Science Committee and Member of the Audit Committee, Member of the Science Committee Member of the Remuneration Committee the Nomination and Governance Committee and the Science Committee Other officers of the Company at 31 December 2008 included members of the Senior Executive Team, as set out on page 86.
John Patterson will retire from the Board on 31 March 2009.
Adrian Kemp was appointed Company Secretary with effect from 1 January 2009, in succession to Graeme Musker who stepped down at the end of 2008 and will retire from the Company in April 2009.
JEAN-phIlIppE CouRToIS 48 RudY mARKhAm 62 Non-Executive Director and Non-Executive Director and Member of the Audit Committee Member of the Audit Committee ASTRAZENECA ANNuAl REpoRT ANd FoRm 20-F INFoRmATIoN 2008 Directors report 85 louIS SChWEITZER JohN BuChANAN JANE hENNEY Appointed as a Director 11 March 2004.
Non-Executive Chairman of Renault SA since Executive Director and Group Chief Financial Currently Professor of Medicine, University April 2005.
Chairman and Chief Executive Officer of BP p. l. c. 1996-2002.
Member of the of Cincinnati.
Prior appointments include: Officer of Renault SA 1992-2005.
Senior Vice-President and Provost for Health Executive Director of BNP-Paribas, Veolia Senior Independent Director of BHP Billiton Plc.
Affairs, University of Cincinnati Medical Environnement, Volvo AB and LOral.
Deputy Chairman of Vodafone Group Plc.
Academic Health Center: Deputy Director, Chairman of Smith & Nephew plc.
Chairman US National Cancer Institute: Deputy dAvId BRENNAN of International Chamber of Commerce UK.
Commissioner for Operations, US Food and Appointed as a Director 14 March 2005.
Drug Administration FDA : and Commissioner Appointed Chief Executive Officer 1 January JohN pATTERSoN CBE FRCp of Food and Drugs, FDA.
Chairman-elect of the Executive Appointed as a Director 1 January 2005.
Director of AmerisourceBergen Corporation Board of the Pharmaceutical Research and Fellow of the Royal College of Physicians.
Other board Manufacturers of America PhRMA to take Director of the British Pharma Group.
appointments include The Commonwealth effect on 3 April 2009.
Honorary Board Non-Executive Director of Cobham plc.
Fund and China Medical Board.
Member of the US CEO Roundtable on Non-Executive Director of Amersham plc Cancer, Board Member of the European 2001-2004.
President of the Association Bo ANGElIN Federation For Pharmaceutical Industries of the British Pharmaceutical Industry ABPI Appointed as a Director 24 July 2007. and Associations EFPIA.
Member of the Supervisory Professor of Clinical Metabolism at Karolinska of the UK Commission for Employment and Board of the UK Medicines Control Agency Institutet and Head of the Department of Skills UKCES.
Endocrinology, Metabolism and Diabetes the Southeastern Chapter of the American at the Karolinska University Hospital in Heart Association 2004-2006. hKAN moGREN KBE Stockholm, Sweden.
Member of the Nobel Appointed as a Director 6 April 1999.
Assembly and of the Swedish Royal Academy SImoN loWTh Formerly Chief Executive Officer and a of Sciences.
Member of the Medical Nobel Appointed as a Director 5 November 2007.
Director of Astra AB appointed 18 May 1988.
Prior appointments include Chairman Also has overall responsibility for Information Member of the Board of Directors of Investor of the Nobel Committee for Physiology Services.
Finance Director, Scottish Power plc AB and Groupe Danone.
Director of the and Medicine.
2005-2007 and Executive Director, Corporate Marianne and Marcus Wallenberg Foundation.
Strategy and Development, Scottish Power Member of the Royal Swedish Academy of JEAN-phIlIppE CouRToIS plc 2003-2005.
Director Head of UK Engineering Sciences.
Industrial Practice, McKinsey & Company President of Microsoft International since 2000-2003. mIChElE hoopER June 2005.
President Microsoft EMEA 2000-2003. mARCuS WAllENBERG President and Chief Executive Officer Corporate Vice-President, Microsoft Appointed as a Director 6 April 1999. of Stadtlander Drug Company 1998-1999.
Formerly a Director of Astra AB appointed Corporate Vice-President and President, Administrator for PlaNet Finance and 18 May 1989.
Chairman of Skandinaviska International Businesses of Caremark representative at the Institut Montaigne.
Director of UnitedHealth Group, PPG RudY mARKhAm Vice-Chairman of Telefonaktiebolaget Industries, Inc. and Warner Music Group, Inc.
Non-Executive Director of Chairman and Non-Executive Director of Stora Enso Oyj, the Knut and Alice dAmE NANCY RoThWEll Moorfields Eye Hospital Foundation Trust.
Wallenberg Foundation and Temasek Appointed as a Director 27 April 2006.
Non-Executive Director of United Parcel Holdings Ltd. Honorary Chairman of Also has responsibility for overseeing Services Inc. Financial Reporting Council, International Chamber of Commerce.
Standard Chartered PLC and Legal & MRC Research Professor and Deputy General plc.
Fellow of the Chartered Institute JohN vARlEY President and Deputy Vice Chancellor at the of Management Accountants and Fellow of Appointed as a Director 26 July 2006.
Council member of the Association of Corporate Treasurers.
Executive Director of Barclays Bank plc and the Biotechnology and Biological Sciences Barclays plc since 1998 and Group Chief Research Council, Vice-President and Executive since 2004.
Chairman of Business Council member of the Royal Society.
Prior Action on Homelessness and President of the appointments include: Trustee of Cancer Employers Forum on Disability and member Research UK and the Campaign for Medical of the International Advisory Panel of the Progress: Chair of the Research Defence Monetary Authority of Singapore.
Honorary Society: Chair of the Wellcome Trust Public President of the UK Drug Policy Commission.
Engagement Strategy Panel: President of the Treasurer and Trustee of St. Dunstans and British Neuroscience Association: and Council Trustee of Thornton Smith & Plevins Young member of the Medical Research Council.
ASTRAZENECA ANNuAl REpoRT ANd FoRm 20-F INFoRmATIoN 2008
